# U.S. Physical Therapy, Inc. (USPH) Stock Analysis: High Potential with a 9.42% Upside

- Link: https://www.directorstalkinterviews.com/u-s-physical-therapy-inc-usph-stock-analysis-high-potential-with-a-9-42-upside/4121268136
- Published: 2026-10-27T11:12:57+00:00
- Author: Madison Wilson

For investors seeking opportunities in the healthcare sector, U.S. Physical Therapy,
Inc. (NYSE: USPH) presents an intriguing prospect. The company, operating within
the medical care facilities industry, is a significant player in the outpatient 
physical therapy market, with a market capitalization of $1.32 billion. Based in
Houston, Texas, USPH has been providing essential physical therapy and industrial
injury prevention services since its inception in 1990.

The stock is currently priced at $88.65, hovering near the upper end of its 52-week
range of $59.00 to $91.00. This stability, coupled with a current price change of
just 0.00%, signals a consistent performance, bringing comfort to investors wary
of volatility.

Valuation metrics reveal a forward P/E ratio of 26.46, suggesting that the market
anticipates growth from USPH. However, other common valuation metrics such as PEG
Ratio, Price/Book, and EV/EBITDA are not available, which could make comprehensive
valuation challenging for some investors.

USPH’s revenue growth of 8.50% reflects a healthy upward trajectory, indicating 
that the company is effectively expanding its operations and increasing its market
share. Despite this growth, the company’s net income figures are currently unavailable,
which might raise questions regarding profitability. The EPS stands at 0.18, and
the return on equity is a modest 6.51%, which suggests that while profitable, the
company may not yet be maximizing its equity returns.

A standout figure in USPH’s financials is its free cash flow of $41.29 million, 
a strong indicator of the company’s ability to fund operations, pay down debt, or
return capital to shareholders. On the dividend front, USPH offers a yield of 2.08%,
but the extraordinarily high payout ratio of 1,011.11% may concern dividend-focused
investors, as it suggests that the company is paying out more in dividends than 
it earns in net income.

Analyst ratings further bolster the stock’s attractiveness, with six buy ratings
and only one hold rating, and no sell ratings. The consensus average target price
is $97.00, suggesting a potential upside of 9.42% from the current price. This optimism
is further reflected in the target price range of $95.00 to $100.00.

From a technical perspective, USPH is trading well above both its 50-day moving 
average of $82.19 and its 200-day moving average of $76.72, indicating a strong 
upward trend. However, the RSI (14) stands at a low 12.93, which could suggest that
the stock is currently oversold, potentially presenting a buying opportunity.

U.S. Physical Therapy, Inc. operates within a niche but growing market, providing
essential services not only to individuals but also to Fortune 500 companies through
its industrial injury prevention services. This dual focus on outpatient care and
industrial health positions USPH uniquely in the healthcare sector.

For investors interested in the healthcare space, particularly those focused on 
physical therapy and corporate health, USPH offers a promising investment opportunity.
With a solid growth trajectory, potential upside, and a robust service offering,
U.S. Physical Therapy, Inc. merits consideration for inclusion in a diversified 
investment portfolio.

Share on:
